Your browser doesn't support javascript.
loading
Changes in general and COVID-19 vaccine hesitancy among U.S. adults from 2021 to 2022.
Nguyen, Kimberly H; Chung, E Lisa; McChesney, Cheyenne; Vasudevan, Lavanya; Allen, Jennifer D; Bednarczyk, Robert A.
Afiliação
  • Nguyen KH; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
  • Chung EL; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
  • McChesney C; Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
  • Vasudevan L; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
  • Allen JD; Department of Community Health, Tufts University, Medford, MA, USA.
  • Bednarczyk RA; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Ann Med ; 56(1): 2357230, 2024 Dec.
Article em En | MEDLINE | ID: mdl-38813804
COVID-19 vaccine hesitancy increased from 40.7% in 2021 to 44.6% in 2022.During the same period, hesitancy regarding both the COVID-19 vaccine and vaccines in general increased among those who were ≥65 years and non-Hispanic White while hesitancy toward COVID-19 vaccines decreased among non-Hispanic Black adults.Belief in the overall social benefit of the COVID-19 vaccine decreased from 47.5% to 25.1%, sug­gesting need to frame messaging on benefits such as protection from severe disease outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hesitação Vacinal Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hesitação Vacinal Idioma: En Ano de publicação: 2024 Tipo de documento: Article